Correlation Between BlackRock Health and Allianzgi Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BlackRock Health and Allianzgi Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BlackRock Health and Allianzgi Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BlackRock Health Sciences and Allianzgi Equity Convertible, you can compare the effects of market volatilities on BlackRock Health and Allianzgi Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BlackRock Health with a short position of Allianzgi Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of BlackRock Health and Allianzgi Equity.

Diversification Opportunities for BlackRock Health and Allianzgi Equity

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between BlackRock and Allianzgi is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding BlackRock Health Sciences and Allianzgi Equity Convertible in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allianzgi Equity Con and BlackRock Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BlackRock Health Sciences are associated (or correlated) with Allianzgi Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allianzgi Equity Con has no effect on the direction of BlackRock Health i.e., BlackRock Health and Allianzgi Equity go up and down completely randomly.

Pair Corralation between BlackRock Health and Allianzgi Equity

Given the investment horizon of 90 days BlackRock Health Sciences is expected to generate 1.16 times more return on investment than Allianzgi Equity. However, BlackRock Health is 1.16 times more volatile than Allianzgi Equity Convertible. It trades about 0.5 of its potential returns per unit of risk. Allianzgi Equity Convertible is currently generating about 0.02 per unit of risk. If you would invest  1,423  in BlackRock Health Sciences on November 1, 2024 and sell it today you would earn a total of  240.00  from holding BlackRock Health Sciences or generate 16.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.0%
ValuesDaily Returns

BlackRock Health Sciences  vs.  Allianzgi Equity Convertible

 Performance 
       Timeline  
BlackRock Health Sciences 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BlackRock Health Sciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain technical and fundamental indicators, BlackRock Health may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Allianzgi Equity Con 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Allianzgi Equity Convertible are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of rather inconsistent forward indicators, Allianzgi Equity may actually be approaching a critical reversion point that can send shares even higher in March 2025.

BlackRock Health and Allianzgi Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BlackRock Health and Allianzgi Equity

The main advantage of trading using opposite BlackRock Health and Allianzgi Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BlackRock Health position performs unexpectedly, Allianzgi Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allianzgi Equity will offset losses from the drop in Allianzgi Equity's long position.
The idea behind BlackRock Health Sciences and Allianzgi Equity Convertible pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance